Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection

Cell Reports(2020)10.1016/j.celrep.2020.03.058Source: DataRank Database

Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)OA: goldTopics (41)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Laughing Bear Torrez Dulgeroff,Michal Caspi Tal ORCID,Hilal Bhat ORCID,Fanghui Li ORCID,Anfei Huang ORCID

Live enrichment

PubMed:32294445 PMC:PMC8369894

Research Training Group

Grant: 1949

Deutsche Forschungsgemeinschaft

Grant: LA1419/7-1

Deutsche Forschungsgemeinschaft

Grant: LA1419/10-1

Stanford

Grant: 5T32AI007290

NRSA

Grant: 1 F32 AI124558-01

NIH

Grant: HHSN266200700002C/N01-AI-70002

NIAID NIH HHS

Grant: T32 AI007290

NIAID NIH HHS

Grant: F32 AI124558

NIAID NIH HHS

Grant: HHSN266200700005C

NIAID NIH HHS

Grant: N01 AI070002

Intramural NIH HHS

Grant: ZIA AI000753

NIAID

National Institute of Allergy and Infectious Diseases, National Institutes of Health

NIH

Deutsche Forschungsgemeinschaft

University of Duisburg-Essen

Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

Virginia and Daniel Ludwig Cancer Foundation

Bay Area Lyme Foundation

Stanford

Virginia and D.K. Ludwig Fund for Cancer Research

National Institutes of Health

goldLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S2211124720303831/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124720303831?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720303831?httpAccept=text/plain

repositoryhttps://escholarship.org/uc/item/7k44g2tk

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8369894

Fields of Study

Adaptive ImmunityAnimalsCD47 AntigenCD8-Positive T-LymphocytesCell LineFemaleHEK293 CellsHumansImmunity, InnateImmunotherapyLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMacrophagesMice, Inbred C57BLMice, KnockoutSignal TransductionVirus Diseases

MeSH Terms

CD8-Positive T-LymphocytesCell LineMacrophagesAnimalsMice, Inbred C57BLMice, KnockoutHumansLymphocytic choriomeningitis virusVirus DiseasesLymphocytic ChoriomeningitisImmunotherapySignal TransductionFemaleImmunity, InnateAdaptive ImmunityHEK293 CellsCD47 Antigen

Keywords

HIV-1Dendritic cellsinnate immunityadaptive immunityCd47LcmvCheckpoint Inhibitors